Prevalence of Mupirocin Resistant Staphylococcus Aureus Isolates Among Patients Admitted to a Tertiary Care Hospital

Overview

Journal N Am J Med Sci

Specialty General Medicine

Date 2014 Sep 12

PMID 25210674

Citations 16

Authors

Parul Chaturvedi

Amit Kumar Singh

Snehanshu Shukla

Loveleena Agarwal

Affiliations

Soon will be listed here.

Abstract

Background: For the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections and decolonization of MRSA carriers, the use of mupirocin a topical antibiotic is increasing day by day.

Aim: The present study was carried out to determine the prevalence rate of high-level and low-level mupirocin resistant MRSA isolates among patients admitted to a tertiary care hospital.

Materials And Methods: This is a prospective study carried out on MRSA isolated from the various clinical specimens from outpatient and inpatient departments during period of one year. A total of 82 MRSA isolates were recovered from 6468 different clinical specimens. Mupirocin resistant MRSA was detected by two different methods: Epsilometer test (E-test) and agar dilution method. D-shaped zone test (D-zone test) was also performed for determination of inducible clindamycin resistance in MRSA isolates.

Results: Out of 82 non-duplicate MRSA isolates mupirocin resistance were found in 15 (18.3%) isolates by both E-test and agar dilution method. Of these 15 mupirocin resistant, 8 (53.3%) isolates were high-level resistant (MuH) and 7 (46.7%) isolates were low-level resistant (MuL). Four isolates were D-zone test positive showing simultaneous inducible clindamycin resistance among mupirocin resistant MRSA isolates.

Conclusion: Higher prevalence of both high-level and low-level of mupirocin resistant MRSA was observed in patient from the population. It is advisable to perform routine test to detect MRSA colonization among health care workers and nasal decolonization to prevent spread of MRSA infections among hospitalized patients.

Citing Articles

Epidemiology of Antimicrobial Resistance Genes in Isolates from a Public Database in a One Health Perspective-Sample Characteristics and Isolates' Sources.

Zaghen F, Sora V, Meroni G, Laterza G, Martino P, Soggiu A Antibiotics (Basel). 2023; 12(7).

PMID: 37508321 PMC: 10376612. DOI: 10.3390/antibiotics12071225.

Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals.

Prakash R, Garg A, Arya R, Kumawat R Sci Rep. 2023; 13(1):10171.

PMID: 37349503 PMC: 10287686. DOI: 10.1038/s41598-023-37399-0.

Evaluation of the antibacterial activity of selected Kenyan medicinal plant extract combinations against clinically important bacteria.

Odongo E, Mutai P, Amugune B, Mungai N, Akinyi M, Kimondo J BMC Complement Med Ther. 2023; 23(1):100.

PMID: 37013533 PMC: 10069043. DOI: 10.1186/s12906-023-03939-4.

Quality improvement study on the effectiveness of intranasal povidone-iodine decolonization on surgery patients.

Hammond E, Kates A, Putman-Buehler N, Watson L, Godfrey J, Riley C Infect Prev Pract. 2023; 5(2):100274.

PMID: 36915470 PMC: 10006740. DOI: 10.1016/j.infpip.2023.100274.

Dissemination of Methicillin-Resistant Staphylococcus aureus Sequence Type 764 Isolates with Mupirocin Resistance in China.

Guo Y, Xu L, Wang B, Rao L, Xu Y, Wang X Microbiol Spectr. 2023; 11(1):e0379422.

PMID: 36622214 PMC: 9927232. DOI: 10.1128/spectrum.03794-22.

References

Arora S, Devi P, Arora U, Devi B . Prevalence of Methicillin-resistant Staphylococcus Aureus (MRSA) in a Tertiary Care Hospital in Northern India. J Lab Physicians. 2011; 2(2):78-81. PMC: 3040078. DOI: 10.4103/0974-2727.72154. View

Hudson I . The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect. 1994; 27(2):81-98. DOI: 10.1016/0195-6701(94)90001-9. View

Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das B, Chaudhry R . Mupirocin resistance in Staphylococcus aureus in an Indian hospital. Diagn Microbiol Infect Dis. 2007; 58(1):125-7. DOI: 10.1016/j.diagmicrobio.2006.10.012. View

Simor A, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin H . Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2006; 44(2):178-85. DOI: 10.1086/510392. View

Graffunder E, Venezia R . Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 2002; 49(6):999-1005. DOI: 10.1093/jac/dkf009. View

Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das B, Chaudhry R . Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Indian J Med Res. 2006; 123(4):571-3. View

de Oliveira N, Cardozo A, de Andrade Marques E, Dos Santos K, deMarval M . Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureus. J Med Microbiol. 2007; 56(Pt 7):937-939. DOI: 10.1099/jmm.0.46965-0. View

Gordon R, Lowy F . Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008; 46 Suppl 5:S350-9. PMC: 2474459. DOI: 10.1086/533591. View

Hurdle J, ONeill A, Mody L, Chopra I, Bradley S . In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother. 2005; 56(6):1166-8. PMC: 3319406. DOI: 10.1093/jac/dki387. View

10.

Rodvold K, McConeghy K . Methicillin-resistant Staphylococcus aureus therapy: past, present, and future. Clin Infect Dis. 2013; 58 Suppl 1:S20-7. DOI: 10.1093/cid/cit614. View

11.

Robicsek A, Beaumont J, Thomson Jr R, Govindarajan G, Peterson L . Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol. 2009; 30(7):623-32. DOI: 10.1086/597550. View

12.

. Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern. Indian J Med Res. 2013; 137(2):363-9. PMC: 3657861. View

13.

Yanagisawa T, Lee J, Wu H, Kawakami M . Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. J Biol Chem. 1994; 269(39):24304-9. View

14.

Hogue J, Buttke P, Braun L, Fairchok M . Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population. J Clin Microbiol. 2010; 48(7):2599-600. PMC: 2897475. DOI: 10.1128/JCM.02118-09. View

15.

Patel J, Gorwitz R, Jernigan J . Mupirocin resistance. Clin Infect Dis. 2009; 49(6):935-41. DOI: 10.1086/605495. View

16.

Prabhu K, Rao S, Rao V . Inducible Clindamycin Resistance in Staphylococcus aureus Isolated from Clinical Samples. J Lab Physicians. 2011; 3(1):25-7. PMC: 3118052. DOI: 10.4103/0974-2727.78558. View

17.

Walker E, Vasquez J, Dula R, Bullock H, Sarubbi F . Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?. Infect Control Hosp Epidemiol. 2003; 24(5):342-6. DOI: 10.1086/502218. View

18.

Sivaraman K, Venkataraman N, Cole A . Staphylococcus aureus nasal carriage and its contributing factors. Future Microbiol. 2009; 4(8):999-1008. PMC: 2908500. DOI: 10.2217/fmb.09.79. View

19.

Rayner C, Munckhof W . Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern Med J. 2005; 35 Suppl 2:S3-16. DOI: 10.1111/j.1444-0903.2005.00976.x. View

20.

Wertheim H, Melles D, Vos M, van Leeuwen W, van Belkum A, Verbrugh H . The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005; 5(12):751-62. DOI: 10.1016/S1473-3099(05)70295-4. View